MedTrace Logo

NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

NCT04231591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2024-03-12

No results posted yet for this study

Summary

The purpose of this study is to determine if NT-BNP levels obtained at time of admission for delivery are predictive of intrapartum or postpartum complications in patients with adult congenital heart disease.

Conditions

  • Congenital Heart Disease
  • Pregnancy Complications

Interventions

DIAGNOSTIC_TEST

NT-proBNP

Collect serum NT-proBNP levels in singleton ACHD patients and a comparative normotensive control group at time of admission for delivery to characterize negative predictive values for intrapartum and postpartum cardiac events.

Sponsors & Collaborators

Principal Investigators

  • Carl H. Rose, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-13
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04231591 on ClinicalTrials.gov